Table 2.

Patient demographics: other therapy.

	No. (%)
Radiation for primary disease	6 (33.3)
Radiation for metastatic disease	9 (50.0)
Radiation for CNS disease	11 (61.1)
Before trial participation	8 (44.4)
After trial participation	3 (16.7)
Surgery for primary disease	13 (72.2)
Surgery for metastatic disease	9 (50.0)
Surgery for CNS disease	5 (27.8)
Before trial participation	5 (27.8)
After trial participation	1 (5.6)
Systemic therapy for primary disease	11 (61)
Systemic therapy for metastatic disease	9 (50.0)
Patients receiving corticosteroids, no. (%)	14 (77.8)

Trial participation defined as time enrolled on study.

CNS central nervous system.